News & Events
- Homepage
- •
- News & Events
News
See all recent news
March 10th, 2020
MedDay Reports Top-Line Data from Phase III Trial “SPI2” for Treatment of Progressive Forms of Multiple Sclerosis
Read more
December 12th, 2019
MedDay Reports Last Patient Study Visit in Second Phase 3 Clinical Trial with MD1003®, an Important Milestone Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis
Read more
July 22nd, 2019
MedDay Pharmaceuticals to webcast key opinion leader meeting on new treatment strategies for progressive forms of multiple sclerosis tomorrow
Read more
Events
See all events
October
03
2019
MedDay attends the 32nd congress of "Association des Neurologues Libéraux de Langue française" (ANLLF) in Strasbourg, France
September
11
2019
MedDay attends the 35th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Stockholm, Sweden. Excited to meet you on our booth C60!
June
29
2019
MedDay attends the 5th congress of the European Academy of Neurology (EAN) in Oslo, Norway. Meet us Booth C34!
May
28
2019
MedDay attends the 2019 Consortium of Multiple Sclerosis Centers (CMSC) Meeting in Seattle, Washington. Meet us at our booth!
April
16
2019